ConductScience.org, home

Paper37553371

Impact of a risk based breast screening decision aid on understanding, acceptance and decision making.

Lippey J and 4 others. NPJ Breast Cancer, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Impact of a risk based breast screening decision aid on understanding, acceptance and decision making. Papers, record 37553371. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37553371

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of a risk based breast screening decision aid on understanding, acceptance and decision making.
PubMed
Journal
NPJ Breast Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2023-11-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lippey JJocelynhttps://orcid.org/0000-0001-9977-1646
2Keogh LLouise
3Campbell IIanhttps://orcid.org/0000-0002-7773-4155
4Mann GBGregory Bruce
5Forrest LELaura Elenorhttps://orcid.org/0000-0002-1126-4971

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PRAC-17-007 2017National Breast Cancer Foundation (NBCF)PubMed

Source PubMed

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122114898Mammographic density and breast cancer risk: current understanding and future prospects.Breast Cancer Res2011https://conductscience.org/library/papers/22114898PubMed
223109704A role for common genomic variants in the assessment of familial breast cancer.J Clin Oncol2012https://conductscience.org/library/papers/23109704PubMed
325751625Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.Nat Genet2015https://conductscience.org/library/papers/25751625PubMed
415755755Model of outcomes of screening mammography: information to support informed choices.BMJ2005https://conductscience.org/library/papers/15755755PubMed
532235552Confusion and Anxiety Following Breast Density Notification: Fact or Fiction?J Clin Med2020https://conductscience.org/library/papers/32235552PubMed
633393021ASO Author Reflections: Will Breast Cancer Screening Become Personalized?Ann Surg Oncol2021https://conductscience.org/library/papers/33393021PubMed
733398646Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions.Ann Surg Oncol2021https://conductscience.org/library/papers/33398646PubMed
825467785Risk determination and prevention of breast cancer.Breast Cancer Res2014https://conductscience.org/library/papers/25467785PubMed
924830599Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.Cancer2014https://conductscience.org/library/papers/24830599PubMed
1031384884Improving breast cancer screening in Australia: a public health perspective.Public Health Res Pract2019https://conductscience.org/library/papers/31384884PubMed
1134703006The current status of risk-stratified breast screening.Br J Cancer2022https://conductscience.org/library/papers/34703006PubMed
1232552763
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
BMC Cancer2020https://conductscience.org/library/papers/32552763PubMed
1331360882The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches.JNCI Cancer Spectr2018https://conductscience.org/library/papers/31360882PubMed
1428944288The WISDOM Study: breaking the deadlock in the breast cancer screening debate.NPJ Breast Cancer2017https://conductscience.org/library/papers/28944288PubMed
1534906505Heterogeneity in how women value risk-stratified breast screening.Genet Med2022https://conductscience.org/library/papers/34906505PubMed
1625708717Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.Breast2015https://conductscience.org/library/papers/25708717PubMed
1735060087Development and pilot testing of an online decision aid for women considering risk-stratified breast screening.J Community Genet2022https://conductscience.org/library/papers/35060087PubMed
1829346471Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.JAMA Oncol2018https://conductscience.org/library/papers/29346471PubMed
1926627479Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.Breast Cancer Res2015https://conductscience.org/library/papers/26627479PubMed
2032361308Impact of adding breast density to breast cancer risk models: A systematic review.Eur J Radiol2020https://conductscience.org/library/papers/32361308PubMed

See all 46 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
39909697Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis.Lancet Public Health2025https://conductscience.org/library/papers/39909697PubMed
39637069Awareness and its determinant factors towards breast examination to detect breast cancer among reproductive age women in Kenya: Multi level analysis of the recent demographic and health survey data.PLoS One2024https://conductscience.org/library/papers/39637069PubMed
37823977Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography.Breast Cancer2024https://conductscience.org/library/papers/37823977PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37553371

GET https://conductscience.org/api/papers/v1/37553371/references?page=2